Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
03/2003
03/20/2003US20030055047 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates
03/20/2003US20030055046 Novel pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054014 Administering fungi spores; aging resistance
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003US20030053957 Degradation-resistant glucocorticosteroid formulations
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2457851A1 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003CA2452194A1 Sustained release pharmaceutical compositions comprising a silicone support material
03/19/2003EP1293213A1 Preventives/remedies for postoperative stress
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292607A2 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292297A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1151746B1 Microcapsules for sustained release of drugs
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003CN1404486A Purified LH (Luteinizing hormone)
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof
03/19/2003CN1403127A Medicine for treating hyperthyroidism and its prepn
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020761A1 Modified human growth hormone
03/13/2003WO2003020744A1 Methylene-4-azasteroids
03/13/2003WO2003020726A1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
03/13/2003WO2003020690A1 Aryl sulfamate derivatives
03/13/2003WO2003020263A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003WO2003020240A2 Therapeutic agent delivery tampon
03/13/2003WO2002100404A3 Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074291A3 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
03/13/2003WO2002072033A3 Chronotherapeutic dosage forms containing glucocorticosteroid
03/13/2003WO2002058706A3 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002022154A3 Pharmaceutical compositions for sustained drug delivery
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003US20030050344 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
03/13/2003US20030050325 Novel compounds of the indolecarboxylic family and use thereof
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/13/2003US20030050292 Applying a hydroalcoholic gel that comprises testosterone to the skin of a male
03/13/2003US20030050289 Combination of drospirenone and an estrogen sulphamate for HRT
03/13/2003US20030049697 Detection of potassium channel modulators for treatment of heart, vascular and endrocrine pathologies; obtain sample, incubate with modulator, monitor effect of modulator on transport protein activity
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2459138A1 Modified human growth hormone
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/13/2003CA2458526A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291023A1 Sustained release compositions
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1291013A2 Storage-stable pharmaceutical compositions
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289519A1 Methods of treating androgen deficiency in men using selective antiestrogens
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003CN1402735A Novel androgens
03/12/2003CN1402732A Nb heterocyclic 8-modified adenosine derivs.
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402704A Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
03/12/2003CN1402703A Tri-substd. phenyl derivs. and analogues
03/12/2003CN1102854C Composition for sustained release of human growth hormone
03/11/2003US6531622 Crytalline form of (s)-2 ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531461 Medicament for the treatment of diabetes
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 290